December 3, 2021 iCoat Medical AB’s CEO, Peder Waern, and CMO, Alireza Biglarnia, will present at […]
The shareholders in iCoat Medical AB (publ), org. nr 559172-8208 (the “Company“), are hereby convened to […]
The European Union Intellectual Property Office (EUIPO) has granted iCoat Medical a financial grant from its […]
iCoat Medical’s nomination committee is proposing that Carl Bjartmar (born 1963) joins the company’s Board of […]
In preparation of its upcoming First In Human trial, iCoat Medical has established a clinical hub […]
Dear shareholders and stakeholders in iCoat Medical AB, I am writing to wish our new shareholders […]
iCoat Medical, the Swedish pharmaceutical company pioneering drug development for comprehensive prevention of the innate immune […]